NCT07042204View on ClinicalTrials.gov

Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

June 3, 2025

Study Completion Date

August 3, 2025

Conditions
Furcation Defects
Interventions
PROCEDURE

Group I (extended platelet-rich fibrin)

mucoperiosteal flap will be raised through sulcular incisions Debridement of granulation tissue from the osseous defect and furcation will be filled with (ePRF) at the first group

PROCEDURE

Group II (bioactive glass nanoparticles mixed with extended platelet-rich fibrin)

bioactive glass nanoparticles mixed with extended platelet-rich fibrin (BGn+ePRF)

PROCEDURE

Group III (bioactive glass nanoparticles and covered by a collagen membrane)

bioactive glass nanoparticles and covered by a collagen membrane

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Merna Nasser Mohamed Mostafa Ibrahim Elnahas

OTHER

NCT07042204 - Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects | Biotech Hunter | Biotech Hunter